from web site
Articles from PLo, S ONE are provided here thanks to
Item Description, SARS-COV2 Antigen Quick Test Card contains a gold-labeled unique coronavirus N protein monoclonal antibody pre-coated on the bonding pad and a paired unique coronavirus N protein monoclonal antibodies xed in the test line (T) and matching antibodies in the quality assurance line (C). SARS-COV2 Antigen Fast Test Set can identify the infection from the rst stage of infection (2-3 days prior to possible symptom beginning) to the last phase of infection (7-10 days after potential symptom beginning).
Gold-labelled SARS-Co, V-2 N protein monoclonal antibodies immobilized on the test area, with matching antibodies in the quality control location. Swabbed specimens from the nasopharynx or oropharyngeal, lead to 15 minutes. Related Source Here -invasive Simple to use Convenient, no devices needed Quick, get a lead to 15 minutes Steady, with high accuracy Inexpensive, cost-efficiency, Related News, On 26th Jan 2021, report from PEI of an official test that The Federal Institute for Drugs and Medical Gadget (Bundesinstitut fr Arzneimittel und Medizinprodukte, Bf, Ar, M) licensed to perform, declared that Lepu Medical SARS-Co, V-2 Antigen Quick Test Set has actually satisfied all the minimum criteria for antigen tests conducted by PEI in consultation with the Robert Koch-Institut (RKI).
The test set makes the coronavirus detection treatments rapid and easy.
Coronavirus disease 2019 (COVID-19), triggered by an extreme intense breathing syndrome coronavirus-2 (SARS-Co, V-2), which can result in pneumonia and severe intense respiratory syndrome, continues to spread out across the globe. Due to rigorous precautionary procedures, the epidemic circumstance of COVID-19 has actually been initially managed in China. Nevertheless, the varieties of validated positive cases of COVID-19 and deaths are increasing in other nations.
Therefore, the rapid and accurate recognition of pathogenic viruses plays an essential role in managing epidemics. Calculated tomography imaging and some hematologic parameters are the initial markers for COVID-19 infection, while viral nucleic acid detection by reverse transcription-polymerase domino effect is utilized as a gold standard for the clinical diagnosis of thought cases.